Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party
The present study aimed at describing the outcome of patients with HIV-associated lymphomas following autologous hematopoietic stem cell transplantation (autoHCT) in the rituximab and combined antiretroviral therapy (cART) era. Eligible for this retrospective study were HIV-positive patients with ly...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 February 2019
|
| In: |
Bone marrow transplantation
Year: 2019, Jahrgang: 54, Heft: 10, Pages: 1625-1631 |
| ISSN: | 1476-5365 |
| DOI: | 10.1038/s41409-019-0480-x |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/s41409-019-0480-x Verlag: https://www.nature.com/articles/s41409-019-0480-x 
|
| Verfasserangaben: | Kai Hübel, Alessandro Re, Ariane Boumendil, Herve Finel, Marcus Hentrich, Stephen Robinson, Christoph Wyen, Mariagrazia Michieli, Edward Kanfer, Jose Luis Diez-Martin, Pascual Balsalobre, Laure Vincent, Wilfried Schroyens, Josep Maria Ribera Santasusana, Nicolaus Kröger, Xaver Schiel, Kate Cwynarski, Albert Esquirol, Aida Botelho Sousa, Chiara Cattaneo, Silvia Montoto, Peter Dreger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1680631403 | ||
| 003 | DE-627 | ||
| 005 | 20230427033258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191029s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41409-019-0480-x |2 doi | |
| 035 | |a (DE-627)1680631403 | ||
| 035 | |a (DE-599)KXP1680631403 | ||
| 035 | |a (OCoLC)1341249547 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hübel, Kai |e VerfasserIn |0 (DE-588)1071675400 |0 (DE-627)82624663X |0 (DE-576)433244364 |4 aut | |
| 245 | 1 | 0 | |a Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era |b a retrospective study by the EBMT Lymphoma Working Party |c Kai Hübel, Alessandro Re, Ariane Boumendil, Herve Finel, Marcus Hentrich, Stephen Robinson, Christoph Wyen, Mariagrazia Michieli, Edward Kanfer, Jose Luis Diez-Martin, Pascual Balsalobre, Laure Vincent, Wilfried Schroyens, Josep Maria Ribera Santasusana, Nicolaus Kröger, Xaver Schiel, Kate Cwynarski, Albert Esquirol, Aida Botelho Sousa, Chiara Cattaneo, Silvia Montoto, Peter Dreger |
| 264 | 1 | |c 25 February 2019 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.10.2019 | ||
| 520 | |a The present study aimed at describing the outcome of patients with HIV-associated lymphomas following autologous hematopoietic stem cell transplantation (autoHCT) in the rituximab and combined antiretroviral therapy (cART) era. Eligible for this retrospective study were HIV-positive patients with lymphoma who received autoHCT between 2007 and 2013. A total of 118 patients were included with a median age of 45 years (range 24-66). Underlying diagnoses were diffuse large B cell lymphoma in 47%, Hodgkin lymphoma in 24%, Burkitt lymphoma in 18%, and plasmablastic lymphoma in 7% of patients. Disease status at autoHCT was complete remission in 44%, partial remission (PR) in 38%, and less than PR in 18% of the patients. With a median follow-up of 4 years, 3-year non-relapse mortality, incidence of relapse, progression-free survival (PFS) and overall survival (OS) were 10%, 27%, 63% and 66%, respectively. By multivariate analysis, disease status less than PR but not CD4+ cell count at the time of autoHCT was a significant predictor of unfavorable PFS and OS. In conclusion, in the era of cART and chemoimmunotherapy, the outcome of autoHCT for HIV-related lymphoma is driven by lymphoma-dependent risk factors rather than by characteristics of the HIV infection. | ||
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d London : Springer Nature, 1997 |g 54(2019), 10, Seite 1625-1631 |h Online-Ressource |w (DE-627)320433366 |w (DE-600)2004030-1 |w (DE-576)091012996 |x 1476-5365 |7 nnas |a Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era a retrospective study by the EBMT Lymphoma Working Party |
| 773 | 1 | 8 | |g volume:54 |g year:2019 |g number:10 |g pages:1625-1631 |g extent:7 |a Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era a retrospective study by the EBMT Lymphoma Working Party |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41409-019-0480-x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41409-019-0480-x |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191029 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 22 |y j | ||
| 999 | |a KXP-PPN1680631403 |e 3531018477 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Kai Hübel, Alessandro Re, Ariane Boumendil, Herve Finel, Marcus Hentrich, Stephen Robinson, Christoph Wyen, Mariagrazia Michieli, Edward Kanfer, Jose Luis Diez-Martin, Pascual Balsalobre, Laure Vincent, Wilfried Schroyens, Josep Maria Ribera Santasusana, Nicolaus Kröger, Xaver Schiel, Kate Cwynarski, Albert Esquirol, Aida Botelho Sousa, Chiara Cattaneo, Silvia Montoto, Peter Dreger"]},"person":[{"family":"Hübel","given":"Kai","role":"aut","display":"Hübel, Kai"},{"display":"Dreger, Peter","role":"aut","given":"Peter","family":"Dreger"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"25 February 2019"}],"recId":"1680631403","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 29.10.2019"],"relHost":[{"pubHistory":["Nachgewiesen 19.1997 -"],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"language":["eng"],"part":{"issue":"10","pages":"1625-1631","extent":"7","text":"54(2019), 10, Seite 1625-1631","year":"2019","volume":"54"},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"London ; Basingstoke ; London","dateIssuedKey":"1997","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedDisp":"1997-"}],"recId":"320433366","physDesc":[{"extent":"Online-Ressource"}],"disp":"Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era a retrospective study by the EBMT Lymphoma Working PartyBone marrow transplantation","id":{"zdb":["2004030-1"],"issn":["1476-5365"],"eki":["320433366"]},"note":["Gesehen am 17.01.25"]}],"id":{"eki":["1680631403"],"doi":["10.1038/s41409-019-0480-x"]},"physDesc":[{"extent":"7 S."}],"language":["eng"],"title":[{"subtitle":"a retrospective study by the EBMT Lymphoma Working Party","title":"Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era","title_sort":"Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era"}]} | ||
| SRT | |a HUEBELKAIDAUTOLOGOUS2520 | ||